Ultragenyx Pharmaceutical is a biopharmaceutical company that develops and markets treatments for rare and ultra-rare genetic diseases. The company's products are designed to address the underlying genetic causes of these diseases. Ultragenyx Pharmaceutical was founded in 2010 and is headquartered in Novato, California. The company has a number of products in development, including treatments for lysosomal storage disorders, metabolic disorders, and skeletal disorders. Ultragenyx Pharmaceutical is committed to improving the lives of patients with rare diseases and has received numerous awards for its work in this area.